• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    Wall Street Looks To Feed Off Apple's Post-Earnings Power But Key Jobs Data May Upset The Cart: Analyst Says 'A Lot Of These Clouds Will Lift' If This Happens

    5/3/24 7:03:32 AM ET
    $AMGN
    $AXL
    $BBAI
    $BJRI
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care
    Auto Parts:O.E.M.
    Consumer Discretionary
    Get the next $AMGN alert in real time by email

    Stocks look set to carry forward the upward momentum on Friday amid some earnings cheer, although a tinge of nervousness is evident ahead of the all-important non-farm payrolls report. A strong labor market would give the nod for the Federal Reserve to stay “higher for longer,” and a wage inflation measure from the report will also be on investors’ radar. Also, a national non-manufacturing activity reading is due for the day.

    Apple, Inc (NASDAQ:APPL) appeased the Street with a quarterly report that was not so bad as feared. The company also announced a massive buyback program and a modest dividend hike. The stock has a little under 6% weighting in the S&P 500 Index.

    FuturesPerformance (+/-)
    Nasdaq 100+0.70%
    S&P 500+0.42%
    Dow+0.83%
    R2K+0.07%

    In premarket trading on Friday, the SPDR S&P 500 ETF Trust (NYSE:SPY) climbed 0.41% to $507.08, and the Invesco QQQ ETF (NASDAQ:QQQ) jumped 0.71% to $429.93, according to Benzinga Pro data.

    Cues From Previous Session:

    Stocks rose solidly on Thursday in a relief rally following the Fed decision, with falling bond yields also working in favor of the market. The major indices opened higher but reversed course and fell below the unchanged line briefly in late-morning trading. Buying resumed thereafter, sending the averages steadily higher.

    In the process, the Nasdaq Composite and the S&P 500 Index snapped a two-session losing streak. Communication services, IT, and consumer discretionary stocks advanced solidly, while health care and material stocks came under selling pressure.

    IndexPerformance (+/-)Value
    Nasdaq Composite+1.51%15,840.96
    S&P 500 Index+0.91%5,064.20
    Dow Industrials+0.85%38,225.66
    Russell 2000+1.81%2,016.11

    Insights From Analysts: The market will likely do well, said Fund Strat’s Tom Lee in a CNBC interview, although he predicated his prediction on a condition. “I know investors are wrestling with a lot of questions in their minds because inflation is higher than expected at the start of the year and rates are higher and stocks are higher, he said.

    Amid the different forecasts for Fed rates, market participants were wondering whether this was a payback period, he added.

    Lee noted that earnings season has been overall good although there is evidence that companies are unable to pass on prices, demand is weak, and wage pressures are prevalent.

    “I think, that’s part of the confusion that’s taking place now. But to me, I’m kind of in the camp that despite all this, it’s all going to come down to whether inflation improves in the next couple of months or the rest of the year,” he said.

    “If it does, a lot of these clouds will lift.”

    Upcoming Economic Data:

    • The Labor Department is due to release its monthly non-farm payrolls report for April at 8:30 a.m. EDT. Economists, on average, expect payroll growth of 240,000, down from the 303,000 pace seen in March. The unemployment rate may have remained unchanged at 3.8% and the annual rate of the average hourly earnings – an inflation measure, may have ticked down from 4.1% to 4.0%.
    • The Institute for Supply Management will release the results of its non -manufacturing sector survey at 10 a.m. EDT. The non-manufacturing purchasing managers’ index for April is expected to improve from 51.4% in March to 52%.
    • Chicago Fed President Austan Goolsbe is scheduled to speak at 7:45 p.m. EDT and New York Fed President John Williams at 8:15 p.m. EDT.

    See also: Best Futures Trading Software

    • Apple climbed about 6% in premarket trading following its quarterly results.
    • Other stocks moving on earnings are Amgen, Inc. (NASDAQ:AMGN) (up over 14%), BigBear.ai Holdings, Inc. (NYSE:BBAI) (down about 12%), BJ’s Restaurants, Inc. (NASDAQ:BJRI) (up over 10%), Cloudflare, Inc. (NYSE:NET) (down about 13%), Coinbase Global, Inc. (NASDAQ:COIN) (down about 3.5%), Five9, Inc. (NASDAQ:FIVN) (up over 5%), Expedia Group, Inc. (NASDAQ:EXPE) (down over 10%), Illumina, Inc. (NASDAQ:ILMN) (down about 4.5%), Live Nation Entertainment, Inc. (NYSE:LYV) (up over 3%), Regency Centers Corporation (NASDAQ:REG) (up over 3%), Tandem Diabetes Care, Inc. (NASDAQ:TNDM) (up over 17.5%) and Opendoor Technologies Inc. (NASDAQ:OPEN) (up about 10%).
    • American Axle & Manufacturing Holdings, Inc. (NYSE:AXL), Cboe Global Markets, Inc. (CBOE: CBOE), Fluor Corporation (NYSE:FLR), The Hershey Company (NYSE:HSY) and Owens & Minor, Inc. (NYSE:OMI), XPO, Inc. (NYSE:XPO) are among the notable companies reporting earnings ahead of the market opening.

    Commodities, Bonds, and Global Equity Markets:

    Crude oil futures rose modestly in early trading after a four-session losing streak and gold futures were found teetering just above the $2,300-an ounce mark.

    The 10-year note yield was flattish at 4.571%, after retreating over 1% on Thursday.

    Bitcoin (CRYPTO: BTC) climbed and traded above the $59K level.

    Asian stocks that were open for trading closed mostly higher, tracking the optimism on Wall Street overnight and the positive earnings report from Apple. The Japanese and Chinese markets remained closed for public holidays. The European markets remained firmly in the green in early trading.

    Read Next: Steve Jobs Wasn’t A Fan, But Apple’s Record Stock Buyback Is So Massive It Dwarfs Valuations Of Boeing, Starbucks, eBay And 415 Other S&P 500 Companies

    Photo via Shutterstock

    Get the next $AMGN alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $AMGN
    $AXL
    $BBAI
    $BJRI

    CompanyDatePrice TargetRatingAnalyst
    Tandem Diabetes Care Inc.
    $TNDM
    3/17/2026$33.00Neutral → Overweight
    Piper Sandler
    Amgen Inc.
    $AMGN
    3/10/2026$350.00Hold
    Jefferies
    BJ's Restaurants Inc.
    $BJRI
    3/6/2026$38.00Neutral
    DA Davidson
    Live Nation Entertainment Inc.
    $LYV
    2/27/2026$193.00Neutral → Buy
    Rothschild & Co Redburn
    Live Nation Entertainment Inc.
    $LYV
    2/25/2026$204.00Overweight
    Wells Fargo
    Tandem Diabetes Care Inc.
    $TNDM
    2/23/2026$50.00Hold → Buy
    Lake Street
    Amgen Inc.
    $AMGN
    2/20/2026$185.00Equal Weight
    Barclays
    Tandem Diabetes Care Inc.
    $TNDM
    2/20/2026$30.00Underperform → Neutral
    BofA Securities
    More analyst ratings

    $AMGN
    $AXL
    $BBAI
    $BJRI
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Illumina and Labcorp expand collaboration to broaden access to precision oncology testing

    SAN DIEGO, March 18, 2026 /PRNewswire/ -- Illumina, Inc. (NASDAQ:ILMN) and Labcorp (NYSE:LH), a global leader of innovative and comprehensive laboratory services, today announced an expanded collaboration to advance precision oncology through innovative applications of next-generation sequencing (NGS) solutions across the healthcare ecosystem. Projects are expected to include promoting equitable access to cancer biomarker testing by bringing it closer to patients through new distributed test offerings; generating evidence to facilitate payer coverage; and developing new tests to address areas of unmet need. "By deepening our collaboration, we'll continue to leverage the strengths of our resp

    3/18/26 9:15:00 AM ET
    $ILMN
    $LH
    Medical Specialities
    Health Care

    Cboe Global Markets Announces Date of First-Quarter 2026 Earnings Release and Conference Call

    CHICAGO, March 17, 2026 /PRNewswire/ -- Cboe Global Markets, Inc. (Cboe: CBOE), a leading global markets operator and pioneer in equity derivatives, will announce its financial results for the first quarter of 2026 before the market opens on Friday, May 1, 2026. A conference call with remarks by the company's senior management will begin at 7:30 a.m. CT (8:30 a.m. ET).  A live audio webcast for the conference call and the presentation that will be referenced during the call will be available on the Investor Relations section of Cboe's website at ir.cboe.com under Events. The pre

    3/17/26 4:30:00 PM ET
    $CBOE

    Three XPO Leaders Named 2026 "Pros to Know" by Supply & Demand Chain Executive Magazine

    GREENWICH, Conn., March 17, 2026 (GLOBE NEWSWIRE) -- XPO (NYSE:XPO), a leading provider of freight transportation in North America, announced today that three of its leaders have been named 2026 "Pros to Know" by Supply & Demand Chain Executive Magazine (SDCE). This is the sixth consecutive year that XPO employees have been recognized by SDCE for their outstanding work in the freight transportation industry.  This year's recipients from XPO are: Ryan Smulan (Top Transportation Innovators), vice president, technology, who leads the technology strategy and execution for XPO's linehaul, dock, and pickup and delivery operations, including the deployment of AI solutions that optimize these cr

    3/17/26 10:30:00 AM ET
    $XPO
    Transportation Services
    Consumer Discretionary

    $AMGN
    $AXL
    $BBAI
    $BJRI
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Director Richmond C Bradford bought $34,050 worth of shares (1,000 units at $34.05) (SEC Form 4)

    4 - BJs RESTAURANTS INC (0001013488) (Issuer)

    3/12/26 4:55:17 PM ET
    $BJRI
    Restaurants
    Consumer Discretionary

    Director Richmond C Bradford bought $34,500 worth of shares (1,000 units at $34.50) (SEC Form 4)

    4 - BJs RESTAURANTS INC (0001013488) (Issuer)

    3/6/26 5:10:47 PM ET
    $BJRI
    Restaurants
    Consumer Discretionary

    Director Richmond C Bradford bought $42,122 worth of shares (1,200 units at $35.10) (SEC Form 4)

    4 - BJs RESTAURANTS INC (0001013488) (Issuer)

    3/5/26 4:30:05 PM ET
    $BJRI
    Restaurants
    Consumer Discretionary

    $AMGN
    $AXL
    $BBAI
    $BJRI
    FDA approvals

    Live FDA approvals issued by the Food and Drug Administration and FDA breaking news

    View All

    $AMGN
    $AXL
    $BBAI
    $BJRI
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    February 28, 2025 - FDA Roundup: February 28, 2025

    For Immediate Release: February 28, 2025 Today, the U.S. Food and Drug Administration is providing an at-a-glance summary of news from around the agency:On Thursday, the FDA approved Odactra to include use in individuals 5 through 11 years of age to treat house dust mite induced nasal inflammation (allergic rhinitis), with or without eye inflammation (conjunctivitis). Odactra is an allergen extract immunotherapy

    2/28/25 5:00:47 PM ET
    $TNDM
    Medical/Dental Instruments
    Health Care

    FDA Approval for REPATHA issued to AMGEN INC

    Submission status for AMGEN INC's drug REPATHA (SUPPL-44) with active ingredient EVOLOCUMAB has changed to 'Approval' on 11/20/2024. Application Category: BLA, Application Number: 125522, Application Classification:

    11/21/24 12:43:07 PM ET
    $AMGN
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    FDA Approval for PAVBLU issued to AMGEN INC

    Submission status for AMGEN INC's drug PAVBLU (ORIG-1) with active ingredient AFLIBERCEPT has changed to 'Approval' on 08/23/2024. Application Category: BLA, Application Number: 761298, Application Classification:

    8/26/24 5:53:38 AM ET
    $AMGN
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    SEC Form 4 filed by Haas Alesia J

    4 - Coinbase Global, Inc. (0001679788) (Issuer)

    3/18/26 4:58:55 PM ET
    $COIN
    Finance: Consumer Services
    Finance

    SEC Form 4 filed by Nalebuff Barry James

    4 - HERSHEY CO (0000047111) (Issuer)

    3/18/26 4:37:20 PM ET
    $HSY
    Specialty Foods
    Consumer Staples

    SEC Form 4 filed by Curoe Timothy William

    4 - HERSHEY CO (0000047111) (Issuer)

    3/18/26 4:34:48 PM ET
    $HSY
    Specialty Foods
    Consumer Staples

    $AMGN
    $AXL
    $BBAI
    $BJRI
    SEC Filings

    View All

    SEC Form 144 filed by The Hershey Company

    144 - HERSHEY CO (0000047111) (Subject)

    3/18/26 9:54:53 AM ET
    $HSY
    Specialty Foods
    Consumer Staples

    SEC Form 144 filed by Cloudflare Inc.

    144 - Cloudflare, Inc. (0001477333) (Subject)

    3/17/26 4:38:35 PM ET
    $NET
    Computer Software: Prepackaged Software
    Technology

    SEC Form 144 filed by Coinbase Global Inc.

    144 - Coinbase Global, Inc. (0001679788) (Subject)

    3/16/26 12:39:08 PM ET
    $COIN
    Finance: Consumer Services
    Finance

    $AMGN
    $AXL
    $BBAI
    $BJRI
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    Tandem Diabetes Care upgraded by Piper Sandler with a new price target

    Piper Sandler upgraded Tandem Diabetes Care from Neutral to Overweight and set a new price target of $33.00

    3/17/26 7:55:10 AM ET
    $TNDM
    Medical/Dental Instruments
    Health Care

    Jefferies initiated coverage on Amgen with a new price target

    Jefferies initiated coverage of Amgen with a rating of Hold and set a new price target of $350.00

    3/10/26 8:40:05 AM ET
    $AMGN
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    DA Davidson initiated coverage on BJ Restaurants with a new price target

    DA Davidson initiated coverage of BJ Restaurants with a rating of Neutral and set a new price target of $38.00

    3/6/26 8:32:59 AM ET
    $BJRI
    Restaurants
    Consumer Discretionary

    $AMGN
    $AXL
    $BBAI
    $BJRI
    Financials

    Live finance-specific insights

    View All

    Cboe Global Markets Announces Date of First-Quarter 2026 Earnings Release and Conference Call

    CHICAGO, March 17, 2026 /PRNewswire/ -- Cboe Global Markets, Inc. (Cboe: CBOE), a leading global markets operator and pioneer in equity derivatives, will announce its financial results for the first quarter of 2026 before the market opens on Friday, May 1, 2026. A conference call with remarks by the company's senior management will begin at 7:30 a.m. CT (8:30 a.m. ET).  A live audio webcast for the conference call and the presentation that will be referenced during the call will be available on the Investor Relations section of Cboe's website at ir.cboe.com under Events. The pre

    3/17/26 4:30:00 PM ET
    $CBOE

    AMGEN ANNOUNCES 2026 SECOND QUARTER DIVIDEND

    THOUSAND OAKS, Calif., March 4, 2026 /PRNewswire/ -- Amgen (NASDAQ:AMGN) today announced that its Board of Directors declared a $2.52 per share dividend for the second quarter of 2026. The dividend will be paid on June 5, 2026, to all stockholders of record as of the close of business on May 15, 2026.About AmgenAmgen discovers, develops, manufactures and delivers innovative medicines to fight some of the world's toughest diseases. Harnessing the best of biology and technology, Amgen reaches millions of patients with its medicines. More than 45 years ago, Amgen helped establish the biotechnology industry at its U.S. headquarters in Thousand Oaks, California, and it remains at the cutting edge

    3/4/26 4:01:00 PM ET
    $AMGN
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    BJ's Restaurants, Inc. Reports Fiscal Fourth Quarter and Fiscal Year 2025 Results

    HUNTINGTON BEACH, Calif., Feb. 25, 2026 (GLOBE NEWSWIRE) -- BJ's Restaurants, Inc. (NASDAQ:BJRI) today reported financial results for its fiscal 2025 fourth quarter and year ended December 30, 2025.        Fiscal Fourth Quarter 2025 Compared to Fourth Quarter 2024 Total revenues increased 3.2% to $355.4 millionComparable restaurant sales increased 2.6%Restaurant level operating profit(1) was $57.2 million, an increase of 8.2%, with restaurant level operating profit margin of 16.1%, an increase of 70 basis pointsDiluted net income per share was $0.58, from diluted net loss per share of $0.23Adjusted diluted net income per share(1) was $0.66, an increase of 39.2% from $0.47Adjusted EBITDA(1

    2/25/26 4:05:00 PM ET
    $BJRI
    Restaurants
    Consumer Discretionary

    $AMGN
    $AXL
    $BBAI
    $BJRI
    Leadership Updates

    Live Leadership Updates

    View All

    Fluor Announces Appointment of Robert G. (Bob) Card to its Board of Directors

    Fluor Corporation (NYSE:FLR) announced today that Robert G. (Bob) Card, former President and CEO of SNC‑Lavalin and a seasoned global engineering and construction executive, has been elected to its Board of Directors effective March 4, 2026. Card will serve on the Board's Audit Committee and Commercial Strategies and Operational Risk Committee. Card's appointment brings the total number of Fluor Board members to 12 of whom 10 are independent. With more than three decades of top‑level management experience across public and private sectors, he contributes broad industry, operational and government expertise. "Bob Card's extensive leadership across the engineering, construction and projec

    3/9/26 6:51:00 AM ET
    $FLR
    Military/Government/Technical
    Industrials

    Fluor Announces Retirement of Executive Chairman, David E. Constable, and Appointment of James T. (Jim) Hackett as Chairman of the Board

    Fluor Corporation (NYSE:FLR) today announced that David E. Constable, Executive Chairman, will step down from the Board of Directors following the Annual Shareholders Meeting on May 6, 2026. James T. (Jim) Hackett, the company's Lead Independent Director, will assume the role of Chairman of the Board on May 5, 2026. Constable's connection to Fluor spans 44 years. He began his career with the company in 1982, advancing through a series of global leadership roles that shaped Fluor's operational and commercial capabilities. After joining the Fluor Board in 2019, he chaired the Commercial Strategies and Operational Risk Committee, later becoming Chief Executive Officer (CEO) in 2021 and Chair

    3/9/26 6:50:00 AM ET
    $FLR
    Military/Government/Technical
    Industrials

    Scorpions Return to Las Vegas With New Headlining Residency at PH Live at Planet Hollywood Resort & Casino Celebrating the Band's 60th Anniversary

    SCORPIONS – COMING HOME TO LAS VEGAS 60+ YEARS OF SCORPIONS SEPTEMBER 17 – OCTOBER 3, 2026 WITH SPECIAL GUEST BUCKCHERRY Presales begin Wednesday, Feb. 18 General on sale begins Saturday, Feb. 21 Scorpions, one of the most iconic and influential hard rock bands of all time, are returning to PH Live at Planet Hollywood Resort & Casino in 2026 with a new headlining residency show. Promoted by Live Nation and Caesars Entertainment, Scorpions – Coming Home to Las Vegas will take place from Thursday, Sept. 17 through Saturday, Oct. 3, 2026, and will once again feature special guest Buckcherry. The new residency follows the band's three previous sold-out runs at the venue: Scorpions – Sin C

    2/17/26 10:00:00 AM ET
    $CZR
    $LYV
    Hotels/Resorts
    Consumer Discretionary
    Services-Misc. Amusement & Recreation

    $AMGN
    $AXL
    $BBAI
    $BJRI
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    Amendment: SEC Form SC 13D/A filed by BigBear.ai Inc.

    SC 13D/A - BigBear.ai Holdings, Inc. (0001836981) (Subject)

    12/16/24 9:09:02 PM ET
    $BBAI
    Computer Software: Prepackaged Software
    Technology

    Amendment: SEC Form SC 13D/A filed by BigBear.ai Inc.

    SC 13D/A - BigBear.ai Holdings, Inc. (0001836981) (Subject)

    12/12/24 4:17:36 PM ET
    $BBAI
    Computer Software: Prepackaged Software
    Technology

    Amendment: SEC Form SC 13D/A filed by BigBear.ai Inc.

    SC 13D/A - BigBear.ai Holdings, Inc. (0001836981) (Subject)

    12/10/24 4:15:32 PM ET
    $BBAI
    Computer Software: Prepackaged Software
    Technology